18,19-Didehydro-16-[(1S)-2,3,4,9-tetrahydro-2-methyl-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan (35226-29-0)

Identification
Name:	18,19-Didehydro-16-[(1S)-2,3,4,9-tetrahydro-2-methyl-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan
Synonyms:	18,19-Didehydro-16-[(1S)-2,3,4,9-tetrahydro-2-methyl-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan;Usambarine
CAS:	35226-29-0
Molecular Formula:	C₃₀H₃₄N₄
Molecular Weight:	0
InChI:	InChI=1/C30H34N4/c1-3-19-18-34-15-13-24-22-9-5-7-11-26(22)32-30(24)28(34)17-20(19)16-27-29-23(12-14-33(27)2)21-8-4-6-10-25(21)31-29/h3-11,19-20,27-28,31-32H,1,12-18H2,2H3/t19-,20-,27-,28-/m0/s1
Molecular Structure:
Properties
Flash Point:	344.5°C
Boiling Point:	646°C at 760 mmHg
Density:	1.26g/cm³
Refractive index:	1.717
Flash Point:	344.5°C
Safety Data

Other Product

17-Norcorynan, 16-(2,3,4,9-tetrahydro-2-methyl-1H-pyrido(3,4-b)indol-1 -yl)-, (16(S))-
(20β)-16-[(1S)-2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan
16-[(1S)-2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan
(20β)-16-[(1R)-2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan
16-[(1R)-2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan
1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
2H-Pyran-5-carboxylicacid, 3-ethenyl-2-(b-D-glucopyranosyloxy)-3,4-dihydro-4-[[(1S)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl]methyl]-,(2S,3R,4S)-
1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14, 17-pentazacycloicosane-4-carboxamide
Indolo[2,3-a]quinolizin-9-ol,3-ethenyl-1,2,3,4,6,7,12,12b-octahydro-2-[[(1S)-2,3,4,9-tetrahydro-2-methyl-1H-pyrido[3,4-b]indol-1-yl]methyl]-,(2S,3R,12bS)-
methyl (19alpha)-19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate - 4-{1-hydroxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}benzene-1,2-diol (1:1)
1H-Pyrido[3,4-b]indol-1-one,2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-2,3,4,9-tetrahydro-9-methyl-
1/C17H22N6/c1-2-8-19-13-11-14(23-10-9-18-12-23)20-16-15(13)21-17(22-16)6-4-3-5-7-17/h9-12,19H,2-8H2,1H
1/C20H20N2/c1-4-10-16(11-5-1)18-19(17-12-6-2-7-13-17)22-20(21-18)14-8-3-9-15-20/h1-2,4-7,10-13H,3,8-9,14-15H
Indolo[2,3-a]quinolizine,3-ethenyl-1,2,3,4,6,7,12,12b-octahydro-9-methoxy-2-[[(1S)-2,3,4,9-tetrahydro-6-methoxy-1H-pyrido[3,4-b]indol-1-yl]methyl]-,(2S,3R,12bS)-
1H-Pyrido[3,4-b]indol-1-one,2-[2-[4-(3-chlorophenyl)-1-piperazinyl]ethyl]-2,3,4,9-tetrahydro-9-methyl-
1H-Pyrido[3,4-b]indol-1-one,2-[3-[4-(2-chlorophenyl)-1-piperazinyl]propyl]-2,3,4,9-tetrahydro-9-methyl-
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14